Items where authors include "Dunn, D."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Gu, X. orcid.org/0000-0002-2202-6792, Watson, C. orcid.org/0000-0002-2469-791X, Agrawal, U. orcid.org/0000-0001-5181-6120 et al. (38 more authors) (2024) Postpandemic sentinel surveillance of respiratory diseases in the context of the World Health Organization mosaic framework: protocol for a development and evaluation study involving the English primary care network 2023-2024. JMIR Public Health and Surveillance, 10. e52047. ISSN 2369-2960

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Gafos, M., Brodnicki, E., Desai, M. et al. (27 more authors) (2017) Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study. PLOS ONE, 12 (4). e0175596.